Dr. Erich Platzer brings expertise in financing startup companies focused on life sciences to Panavance. He is currently the chairman of Alzheimer company Vivoryon Therapeutics NV (Euronext, Amsterdam) and board member of oncology focused Aptose Biosciences Inc (NASDAQ, TSE). He serves as Chairman or board member of Swiss private companies AOT, LMD, and Peripal. He is a Board member and HealthcarePartner of Swiss VC firm MTIP which is focused on digital health. Dr. Platzer has been a Business Angel since 2010; and President of StartAngelsNetwork, Switzerland. From 2001 to 2015 he was co-founder and investment advisor of HBM BioVentures (now HBM Healthcare Invest­ments). He has had multiple roles as chairman or board member of various biotech companies, public or private. Dr. Platzer spent 10 years at Roche (development and business) with his last position as therapeutic area head business oncology. Prior to his roles in industry he spent 12 years in academic medicine and research and was the co-lead team that purified human G-CSF at MSKCC, licensed to Amgen (Neupogen®). Dr Platzer is board certified for Internal Medicine, Hematology and Medical Oncology.  He is a medical faculty member at University of Erlangen, Germany since 1989: Dr. med. habil (~M.D.Ph.D.).